Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Fox

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|April 1, 1995
The interaction with tubulin of a series of stilbenes based on combretastatin A-4J A Woods, J A Hadfield, G R Pettit, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatinC Ewen, A Perera, J H Hendry, et al.
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
Anti-Cancer Drugs|October 1, 1994
Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-onesJ A Hadfield, V H Pavlidis, A T McGown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pumpM Hrubisko, A T Mc Gown, J A Prendiville, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)R Harrison, C A McAuliffe, A Zaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
British Journal of Cancer|June 1, 1988
A phase I and pharmacokinetic study of amphethinileD B Smith, C Ewen, J Mackintosh, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|April 1, 1995
The interaction with tubulin of a series of stilbenes based on combretastatin A-4J A Woods, J A Hadfield, G R Pettit, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatinC Ewen, A Perera, J H Hendry, et al.
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
Anti-Cancer Drugs|October 1, 1994
Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-onesJ A Hadfield, V H Pavlidis, A T McGown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pumpM Hrubisko, A T Mc Gown, J A Prendiville, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)R Harrison, C A McAuliffe, A Zaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
British Journal of Cancer|June 1, 1988
A phase I and pharmacokinetic study of amphethinileD B Smith, C Ewen, J Mackintosh, et al.
Pageof 10